Insights

Speaking Engagement | 02.25.25, 5:45 PM EST

"Supporting Regulatory Compliance Laws," Charting a Path for Compliance in Life Sciences

Speaking Engagement | 12.03.24

29th Annual Drug & Medical Device Litigation Conference

Speaking Engagement | 10.24.24

Do We Need a New Approach for Investing and Raising Funds in This Election Cycle?: A Fireside Chat and Networking Event for Emerging Companies and Investors

Speaking Engagement | 03.22.17

“Orphan Drugs and Market Exclusivity," Medicines for Europe, Legal Affaire Conference, London, U.K.

Speaking Engagement | 03.22.17

"Roundtable on UPC Developments," Medicines for Europe, Legal Affaire Conference, London, U.K.

Speaking Engagement | 06.23.15

"Corporate Counsel Litigation Forum: Strategies & Trends in Effective Value-Based Billing," Crowell & Moring's Corporate Counsel Litigation Forum Webinar Series

Speaking Engagement | 05.27.15

"Cooperating Safely with Competitors," International Chamber of Commerce UK Compliant Collaboration Workshop, London

Speaking Engagement | 05.13.15

"Health Care Industry Emerging Legal Issues Webinar Series - Health Care Antitrust Update: Accountable, Coordinated, and Reformed, So What's New?" Crowell & Moring Webinar

Speaking Engagement | 06.06.14

"Timing is Everything: Managing the Logistics of the BPCIA Exchange Process and Preparing for "Early" and "Late" Phase Litigation," ACI - Biosimilars: The Definitive Forum on the Legal, Regulatory, Patent, and Commercial Realities of Biosimilars

Speaking Engagement | 02.27.14

"Interim and Cross-Border Injunctions Against Pharmaceutical Patent Infringement," ERA Annual Conference on EU Law in the Pharmaceutical Sector

Speaking Engagement | 05.14.12

"Patent Settlement Agreements: A Generic Standpoint," SMi’s Generics, Supergenerics and Patent Strategies conference - London, UK

Speaking Engagement | 03.23.12

"Update on the Unified Patent Court and the Unitary Patent and Implications for the Industry," 8th Legal EGA Affairs Forum

Speaking Engagement | 01.31.12

"Disclosure of Prior Art and Forthcoming Antitrust Issues," C5's 4th Annual Conference on 'Pharma & Biotech Patent Litigation', Amsterdam

Speaking Engagement | 03.17.11

"A review of key cases affecting generic companies," 7th EGA Legal Affairs Forum, Brussels

Speaking Engagement | 02.17.11

"Patent strategies towards generics," ERA Training of national judiciaries, Trier, Germany

Speaking Engagement | 10.07.10

"Eye on the Federal Circuit and District Courts: Life Cycle Lessons Derived from Paragraph IV Litigation," American Conference Institute's 11th Annual Maximizing Pharmaceutical Patent Life Cycles

Speaking Engagement | 04.16.10

"Competition law, patent strategies and patent settlements," ERA - Biennial Conference on European Pharmaceutical Law, Brussels (Belgium)

Speaking Engagement | 11.27.09

"The pharmaceutical sector inquiry," Seminar De Clerq Brants & Partners "Patenting life sciences in 2009: A system in (di)stress or a time of opportunities," Sint-Martens-Latem, Belgium

Speaking Engagement | 11.19.09

"Application of patent litigation strategies to biosimilars: is there a difference?," Informa Life Sciences' 6th Annual Biosimilars Conference, Berlin, Germany

Speaking Engagement | 07.14.09

EC Pharmaceutical Sector Inquiry Lunch Seminar, Final Report, Brussels, Belgium